There is a newer version of the record available.

Published June 26, 2022 | Version 3
Journal article Restricted

BCG vaccination excludes Crohn's disease relapse.

  • 1. Internist

Description

Background.

The incidence of nontuberculous mycobacterial (NTM) infections including Mycobacterium
avium subspecies paratuberculosis (MAP) infections is increasing worldwide. Should we rely on
the protective effect of BCG vaccination of humans against NTM too?

Methods.

The relationship between BCG vaccination and Crohn’s disease relapse has been re-analysed


Results.

The data of the study of Burnham et al. are to some extent biased. Nonetheless, the evidence
provided by the study of Burnham et al. cannot be ignored.


Conclusion.

BCG vaccination excludes Crohn’s disease relapse.

Notes

\href{https://doi.org/10.5281/zenodo.7806243}{Zenodo}

Files

Restricted

The record is publicly accessible, but files are restricted to users with access.